Haematological malignancies
Gene: BLM
Well-established gene-disease association; more than 10 unrelated individuals; multiple BLM deficient mouse models demonstrate BS phenotypes such as a high rate of sister-chromatid exchange, immunoglobulin deficiency and development of a variety of cancers (Hodgkin lymphoma/ Leukaemia).
Individuals reported as homozygous and compound heterozygous variants (missense, and small deletions/insertion/duplications) identified, resulting in premature protein truncation due to induced stop codons.
PMID: 17407155 (2007). In survey of 135 affected individuals, 64 different mutations were identified in 125 individuals.
In 102/125 individuals, the mutations identified were recurrent (shared by two or more individuals). Ethnic affiliations of the individuals with recurrent variants indicate founder mutations (inherited from a common ancestor); high frequency in Eastern European Jewish (Ashkenazi) population.Created: 26 Aug 2021, 3:29 p.m. | Last Modified: 26 Aug 2021, 3:29 p.m.
Panel Version: 0.8953
Mode of inheritance
BIALLELIC, autosomal or pseudoautosomal
Phenotypes
Bloom Syndrome MIM# 210900; Short stature, dysmorphic facies; sun-sensitive; immunoglobulin deficiency (IgA, IgG, IgM); erythema; marrow failure; leukaemia; lymphoma; chromosomal instability; predisposition to malignancies
Publications
gene: BLM was added gene: BLM was added to Haematological malignancies cancer susceptibility. Sources: Curated sources,Expert Review Green Mode of inheritance for gene: BLM was set to BIALLELIC, autosomal or pseudoautosomal Publications for gene: BLM were set to 28297620; Cancer Gene Census Phenotypes for gene: BLM were set to Bloom syndrome, OMIM:210900